PRO-ARRHYTHMIC POTENTIAL OF ORAL ANTIHISTAMINES (H1): COMBINING ADVERSE EVENT REPORTS DATA WITH DRUG UTILIZATION DATA ACROSS EUROPE

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	O10-O11
Journal	Pharmacoepidemiology and Drug Safety
Volume	27
Issue number	7
Publication status	Published - Jul 2018
Externally published	Yes

Cite this

@article{eab2fb99429642e18d250ec38add57b9,

title = "PRO-ARRHYTHMIC POTENTIAL OF ORAL ANTIHISTAMINES (H1): COMBINING ADVERSE EVENT REPORTS DATA WITH DRUG UTILIZATION DATA ACROSS EUROPE",

author = "E. Poluzzi and E. Raschi and B. Godman and A. Koci and U. Moretti and M. Kalaba and B. Wettermark and M. Sturkenboom and \{De Ponti\}, F.",

year = "2018",

month = jul,

language = "English",

volume = "27",

pages = "O10--O11",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley \& Sons Inc.",

number = "7",

}

TY - JOUR

T1 - PRO-ARRHYTHMIC POTENTIAL OF ORAL ANTIHISTAMINES (H1): COMBINING ADVERSE EVENT REPORTS DATA WITH DRUG UTILIZATION DATA ACROSS EUROPE

AU - Poluzzi, E.

AU - Raschi, E.

AU - Godman, B.

AU - Koci, A.

AU - Moretti, U.

AU - Kalaba, M.

AU - Wettermark, B.

AU - Sturkenboom, M.

AU - De Ponti, F.

PY - 2018/7

Y1 - 2018/7

M3 - Meeting Abstract

SN - 1053-8569

VL - 27

SP - O10-O11

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - 7

ER -